Companies: 10,795·Total market cap: $144.5T
Guerbet S.A.

Guerbet S.A.

GUERFOTCHealthcare
$22.25
+$0.00(+0.00%)
Market Cap$281025977
P/E Ratio
52W High$58.35
52W Low$22.25
Overview

Guerbet S.A.(GUERF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GUERF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$3.25guerf eps ttm · guerf earnings per shareEarnings history
PE Ratio (TTM)6.8×guerf pe ratio ttm · guerf price to earningsPE Ratio deep dive
Revenue (TTM)$1.6Bguerf revenue ttm · guerf annual revenueFull revenue history
Dividend Yield不分红does guerf pay dividends · guerf dividend yieldDividend history
Shares Outstanding12.6Mguerf shares outstanding · guerf floatShares outstanding history
Next EarningsTBAguerf earnings date · guerf next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$841.1M▲ +5.71% YoY
202220232024
guerbet s.a. revenue · guerf revenue 2024
FY 2024Net Income$16.1M▼ 32.61% YoY
202220232024
guerbet s.a. net income · guerf profit 2024
FY 2024EPS$1.28▼ 32.63% YoY
202220232024
guerf eps · guerbet s.a. earnings per share 2024
TTM:Revenue: $1.64BNet Income: $40.0MEPS: $3.25View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+0.00%

关于 Guerbet S.A.

CEODavid Hale
IPO DateApr 3, 2017
Employees2,839
CountryFR

Guerbet S.A. focuses on pioneering and distributing contrast media, advanced delivery systems, medical devices, and associated technological solutions. Their product lineup features several iodinated …

what is guerbet s.a. · guerf stock overview · guerbet s.a. company profile · who is guerbet s.a. ceo · guerf OTC · guerbet s.a. headquarters · guerbet s.a. business segments

关于股票概览与关键数据

Guerbet S.A.(GUERF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Apr 3, 2017 在 OTC 上市。截至最近交易日,GUERF 股价为 $22.25,市值约为 $281.0M。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。

2024 财年 Guerbet S.A. 营收 $841.1M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Guerbet S.A.(GUERF)股价为 $22.25,在 OTC 上市,52周区间为 $22.25 – $58.35。

GUERF 最新股价GUERF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议